940

500126

PGHL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PROCTER & GAMBLE HEALTH L Share Price Update

As of the latest trading session, PROCTER & GAMBLE HEALTH L is trading at ₹6060, up by ₹29.50 or 0.48% from its previous close. The stock has moved between ₹5993.50 and ₹6090.00 today. Over the past year, the stock has delivered a return of 5.31%. In the last month, it has returned 17.70%.

PROCTER & GAMBLE HEALTH L performance

Today’s low Today’s high
₹ 5993.50 ₹ 6090.00
₹ 6030.50
52 week low 52 week high
₹ 4707.00 ₹ 6739.00
₹ 6030.50
Open Price ₹ 6000.00
Prev. Close ₹ 6030.50
Volume (Shares) 14718.00
Total traded value ₹ 887.56
Upper Circuit ₹ 7236.50
Lower Circuit ₹ 4824.50
info

Investment Returns

Over 1 Month 17.70% Over 3 Months 21.56% Over 6 Months 4.22% Over 1 Year 5.31%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PROCTER & GAMBLE HEALTH L fundamentals


  • Market cap (Cr) 10,010.30
  • P/E Ratio (TTM) 30.80
  • Beta 0.41
  • Book Value / share 316.00
  • Return on equity 58.14%
  • EPS (TTM) 196.94
  • Dividend yield 6.84%
  • Net profit/quarter (Cr) 94.60
info icon alternate text
  • Market cap (Cr) 10,016.10
  • P/E Ratio (TTM) 30.61
  • Beta 0.33
  • Book Value / share 316.00
  • Return on equity 58.14%
  • EPS (TTM) 196.94
  • Dividend yield 6.84%
  • Net profit/quarter (Cr) 94.60
info icon alternate text

PROCTER & GAMBLE HEALTH L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 370.45
Operating Expense 241.24
Net Profit 94.60
Net Profit Margin (%) 25.53
Earnings Per Share (EPS) 56.99
EBITDA 139.59
Effective Tax Rate (%) 28.98
Particulars DEC 2025 (Values in Cr)
Revenue 373.86
Operating Expense 269.40
Net Profit 77.59
Net Profit Margin (%) 20.75
Earnings Per Share (EPS) 46.74
EBITDA 114.82
Effective Tax Rate (%) 28.69
Particulars SEP 2025 (Values in Cr)
Revenue 324.92
Operating Expense 210.85
Net Profit 88.54
Net Profit Margin (%) 27.24
Earnings Per Share (EPS) 53.34
EBITDA 125.22
Effective Tax Rate (%) 25.60
Particulars JUN 2025 (Values in Cr)
Revenue 338.74
Operating Expense 253.96
Net Profit 66.18
Net Profit Margin (%) 19.53
Earnings Per Share (EPS) 39.87
EBITDA 94.37
Effective Tax Rate (%) 25.48
Particulars MAR 2025 (Values in Cr)
Revenue 310.99
Operating Expense 235.57
Net Profit 61.18
Net Profit Margin (%) 19.67
Earnings Per Share (EPS) 36.86
EBITDA 84.03
Effective Tax Rate (%) 22.09
Particulars MAR 2026 (Values in Cr)
Revenue 1407.97
Operating Expense 975.44
Net Profit 326.91
Net Profit Margin (%) 23.21
Earnings Per Share (EPS) 196.94
EBITDA 474.00
Effective Tax Rate (%) 27.33
Particulars MAR 2025 (Values in Cr)
Revenue 934.17
Operating Expense 632.90
Net Profit 234.41
Net Profit Margin (%) 25.09
Earnings Per Share (EPS) 141.22
EBITDA 328.74
Effective Tax Rate (%) 24.77
Particulars JUN 2024 (Values in Cr)
Revenue 1151.26
Operating Expense 873.38
Net Profit 200.98
Net Profit Margin (%) 17.45
Earnings Per Share (EPS) 121.07
EBITDA 301.44
Effective Tax Rate (%) 26.46
Particulars JUN 2023 (Values in Cr)
Revenue 1229.62
Operating Expense 933.81
Net Profit 229.47
Net Profit Margin (%) 18.66
Earnings Per Share (EPS) 138.23
EBITDA 343.07
Effective Tax Rate (%) 26.96
Particulars JUN 2022 (Values in Cr)
Revenue 1114.41
Operating Expense 874.22
Net Profit 192.52
Net Profit Margin (%) 17.27
Earnings Per Share (EPS) 115.98
EBITDA 280.87
Effective Tax Rate (%) 24.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 323.47
ROE % 58.14
ROCE % 71.75
Total Debt to Total Equity 0.02
EBITDA Margin 35.19
Particulars JUN 2024 (Values in Cr)
Book Value / Share 324.24
ROE % 31.18
ROCE % 39.76
Total Debt to Total Equity 0.02
EBITDA Margin 26.18
Particulars JUN 2023 (Values in Cr)
Book Value / Share 452.34
ROE % 33.56
ROCE % 43.16
Total Debt to Total Equity 0.01
EBITDA Margin 27.90
Particulars JUN 2022 (Values in Cr)
Book Value / Share 371.38
ROE % 29.17
ROCE % 35.97
Total Debt to Total Equity 0.01
EBITDA Margin 25.20
Particulars JUN 2021 (Values in Cr)
Book Value / Share 423.92
ROE % 21.96
ROCE % 27.53
Total Debt to Total Equity 0.00
EBITDA Margin 26.18
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 188.55
Total Assets 794.20
Total Liabilities 794.20
Total Equity 536.96
Share Outstanding 1
Price to Book Ratio 15.90
Return on Assets (%) 29.51
Return on Capital (%) 43.66
Particulars JUN 2024 (Values in Cr)
Cash & Short Term Investments 244.36
Total Assets 794.36
Total Liabilities 794.36
Total Equity 538.24
Share Outstanding 1
Price to Book Ratio 15.57
Return on Assets (%) 25.30
Return on Capital (%) 37.34
Particulars JUN 2023 (Values in Cr)
Cash & Short Term Investments 440.22
Total Assets 1101.19
Total Liabilities 1101.19
Total Equity 750.89
Share Outstanding 1
Price to Book Ratio 11.60
Return on Assets (%) 20.83
Return on Capital (%) 30.56
Particulars JUN 2022 (Values in Cr)
Cash & Short Term Investments 324.53
Total Assets 888.12
Total Liabilities 888.12
Total Equity 616.49
Share Outstanding 1
Price to Book Ratio 11.27
Return on Assets (%) 21.67
Return on Capital (%) 31.23
Particulars JUN 2021 (Values in Cr)
Cash & Short Term Investments 468.91
Total Assets 986.16
Total Liabilities 986.16
Total Equity 703.71
Share Outstanding 1
Price to Book Ratio 13.20
Return on Assets (%) 17.92
Return on Capital (%) 25.12
Particulars MAR 2025 (Values in Cr)
Net Income 311.62
Cash from Operations 250.01
Cash from Investing 9.59
Cash from Financing -234.74
Net change in Cash -56.46
Free Cash Flow 258.57
Particulars JUN 2024 (Values in Cr)
Net Income 273.32
Cash from Operations 313.48
Cash from Investing -6.87
Cash from Financing -418.11
Net change in Cash -196.69
Free Cash Flow 335.21
Particulars JUN 2023 (Values in Cr)
Net Income 314.20
Cash from Operations 325.67
Cash from Investing -21.50
Cash from Financing -98.49
Net change in Cash 116.02
Free Cash Flow 368.15
Particulars JUN 2022 (Values in Cr)
Net Income 253.37
Cash from Operations 233.38
Cash from Investing -25.54
Cash from Financing -288.63
Net change in Cash -144.65
Free Cash Flow 271.30
Particulars JUN 2021 (Values in Cr)
Net Income 233.28
Cash from Operations 315.38
Cash from Investing -32.27
Cash from Financing -386.63
Net change in Cash -171.64
Free Cash Flow 367.96
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2203.65 36.57 16.46 37331.16 2184.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

PROCTER & GAMBLE HEALTH L shareholding pattern

Holding
28.31%
51.81%
6.19%
13.67%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

PROCTER & GAMBLE HEALTH L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
6030.50 -0.53 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 5939.00
  • 26 Days 5465.80
  • 10 Days 5755.50
  • 50 Days 5316.20
  • 12 Days 5700.70
  • 100 Days 5316.50
  • 20 Days 5543.40
  • 200 Days 5428.70
6072.17 PIVOT
First Support 5974.83 First Resistance 6160.33 Second Support 5886.67 Second Resistance 6257.67 Third Support 5789.33 Third Resistance 6345.83
RSI 71.51 ADX 44.02 MACD 234.84 Williams % R -39.01 Commodity Channel Index (CCI) 155.87
Date 2026-06-01 Week 37515.00 Same Day 28717.00 Month 17451.00
1 Year 0.41 3 Year 0.39
Over 1 Month
17.70% down
Over 1 Year
5.31% down
Over 3 Months
21.56% down
Over 3 Years
5.08% down
Over 6 Months
4.22% down
Over 5 Years
0.72% down

PROCTER & GAMBLE HEALTH L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
12 Feb 2026 50.0 Special 12 Feb 2026 Equity shares
12 Feb 2026 110.0 Interim 12 Feb 2026 Equity shares
22 Aug 2025 45.0 Final 22 Aug 2025 Equity shares
21 Feb 2025 80.0 Interim 21 Feb 2025 Equity shares
28 Nov 2024 60.0 Final 29 Nov 2024 Equity shares
14 Feb 2024 150.0 Special 14 Feb 2024 Equity shares
14 Feb 2024 50.0 Interim 14 Feb 2024 Equity shares
23 Nov 2023 50.0 Final 24 Nov 2023 Equity shares
13 Feb 2023 45.0 Interim 13 Feb 2023 Equity shares
15 Nov 2022 11.5 Final 17 Nov 2022 Equity shares
12 May 2022 41.0 Interim 13 May 2022 Equity shares
02 Nov 2021 90.0 Special 05 Nov 2021 Equity shares
02 Nov 2021 40.0 Final 05 Nov 2021 Equity shares
18 Nov 2020 188.0 Special 20 Nov 2020 Equity shares
18 Nov 2020 42.0 Final 20 Nov 2020 Equity shares
23 May 2019 416.0 Special 25 May 2019 Equity shares
23 May 2019 24.0 Final 25 May 2019 Equity shares
21 May 2018 15.0 Final 23 May 2018 Equity shares
25 May 2017 11.0 Final 29 May 2017 Equity shares
22 Apr 2016 7.5 Final 26 Apr 2016 Equity shares
30 Mar 2015 6.0 Final 06 Apr 2015 Equity shares
10 Mar 2014 8.5 Final 12 Mar 2014 Equity shares
07 Mar 2013 2.5 Final 09 Mar 2013 Equity shares
22 Oct 2010 95.0 Interim 25 Oct 2010 Equity shares
18 Mar 2010 20.0 Final 20 Mar 2010 Equity shares
06 Apr 2009 17.5 Final 09 Apr 2009 Equity shares
04 Apr 2008 10.0 Final 08 Apr 2008 Equity shares
21 Mar 2007 10.0 Interim 23 Mar 2007 Equity shares
21 Mar 2007 20.0 Final 23 Mar 2007 Equity shares
12 Apr 2006 0.0 Final 15 Apr 2006 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
12 Feb 2026 50.0 Special 12 Feb 2026 Equity shares
12 Feb 2026 110.0 Interim 12 Feb 2026 Equity shares
22 Aug 2025 45.0 Final 22 Aug 2025 Equity shares
21 Feb 2025 80.0 Interim 21 Feb 2025 Equity shares
28 Nov 2024 60.0 Final 29 Nov 2024 Equity shares
14 Feb 2024 150.0 Special 14 Feb 2024 Equity shares
14 Feb 2024 50.0 Interim 14 Feb 2024 Equity shares
23 Nov 2023 50.0 Final 24 Nov 2023 Equity shares
13 Feb 2023 45.0 Interim 13 Feb 2023 Equity shares
15 Nov 2022 11.5 Final 17 Nov 2022 Equity shares
12 May 2022 41.0 Interim 13 May 2022 Equity shares
02 Nov 2021 90.0 Special 05 Nov 2021 Equity shares
02 Nov 2021 40.0 Final 05 Nov 2021 Equity shares
18 Nov 2020 188.0 Special 20 Nov 2020 Equity shares
18 Nov 2020 42.0 Final 20 Nov 2020 Equity shares
23 May 2019 416.0 Special 25 May 2019 Equity shares
23 May 2019 24.0 Final 25 May 2019 Equity shares
21 May 2018 15.0 Final 23 May 2018 Equity shares
25 May 2017 11.0 Final 29 May 2017 Equity shares
22 Apr 2016 7.5 Final 26 Apr 2016 Equity shares
30 Mar 2015 6.0 Final 06 Apr 2015 Equity shares
10 Mar 2014 8.5 Final 12 Mar 2014 Equity shares
07 Mar 2013 2.5 Final 09 Mar 2013 Equity shares
22 Oct 2010 95.0 Interim 25 Oct 2010 Equity shares
18 Mar 2010 20.0 Final 20 Mar 2010 Equity shares
06 Apr 2009 17.5 Final 09 Apr 2009 Equity shares
04 Apr 2008 10.0 Final 08 Apr 2008 Equity shares
21 Mar 2007 10.0 Interim 23 Mar 2007 Equity shares
21 Mar 2007 20.0 Final 23 Mar 2007 Equity shares
12 Apr 2006 0.0 Final 15 Apr 2006 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Procter & Gamble Health Ltd?

Answer Field

Procter & Gamble Health Ltd share price is for NSE ₹ 6,060.00 & for BSE ₹ 6,057.50 as on Jun 03 2026 12:44 PM.

What is the Market Cap of Procter & Gamble Health Ltd Share?

Answer Field

The market cap of Procter & Gamble Health Ltd for NSE ₹ 10,010.30 & for BSE ₹ 0.00 as on Jun 03 2026 12:44 PM.

What is the 52 Week High and Low of Procter & Gamble Health Ltd?

Answer Field

The 52 Week High and Low of Procter & Gamble Health Ltd for NSE is ₹ 6,739.00 and ₹ 4,707.00 and for BSE is ₹ 6,701.40 and ₹ 4,699.70.

What is 1 year return for Procter & Gamble Health Ltd?

Answer Field

The 1 year returns on the stock has been 5.31%.

What is the P/E Ratio of Procter & Gamble Health Ltd Share?

Answer Field

As on Jun 03 2026 12:44 PM the price-to-earnings (PE) ratio for Procter & Gamble Health Ltd share is 30.80.

What is the PB ratio of Procter & Gamble Health Ltd Share?

Answer Field

As on Jun 03 2026 12:44 PM, the price-to-book (PB) ratio for Procter & Gamble Health Ltd share is 316.00.

How to Buy Procter & Gamble Health Ltd Share?

Answer Field

You can trade in Procter & Gamble Health Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Procter & Gamble Health Ltd Share on Bajaj Broking App?

Answer Field

To buy Procter & Gamble Health Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Procter & Gamble Health Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|